Search research articles
Contact Us
Filters
Showing results (1-10 of 62) with videos related to
Page
of 7
Sort By:
The Lancet. Gastroenterology & Hepatology
|
April 14, 2017
A plea for TDM-based optimisation for treatment of Crohn's disease
Margien L Seinen, Nanne K de Boer
Alimentary Pharmacology & Therapeutics
|
August 16, 2025
Editorial: Dual Advanced Therapy in Refractory Ulcerative Colitis-Hope Beyond Monotherapy
Ahmed B Bayoumy, Nanne K de Boer
Journal of Crohn'S & Colitis
|
January 13, 2022
The Thiopurine Tale: An Unexpected Journey
Femke Crouwel, Hans J C Buiter, Nanne K de Boer
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 7, 2020
Discontinuation rate of azathioprine
Femke Crouwel, Hans J C Buiter, Nanne K de Boer
Journal of Crohn'S & Colitis
|
July 12, 2020
Gut microbiota-driven drug metabolism in inflammatory bowel disease
Femke Crouwel, Hans J C Buiter, Nanne K de Boer
Journal of Crohn'S & Colitis
|
January 9, 2022
The Launch of an Online National Multidisciplinary Expert Panel for Inflammatory Bowel Disease
Nanne K de Boer, Florine L van Lookeren, Greetje J Tack
Clinical Pharmacokinetics
|
August 10, 2015
Pharmacology and Optimization of Thiopurines and Methotrexate in Inflammatory Bowel Disease
Mehmet Coskun, Casper Steenholdt, Nanne K de Boer, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
March 21, 2019
Key insights from therapeutic drug monitoring in Crohn's disease patients
Margien L Seinen, Nanne K De Boer, Adriaan A van Bodegraven
Inflammatory Bowel Diseases
|
December 23, 2017
Thiopurine Treatment in Ulcerative Colitis: A Critical Review of the Evidence for Current Clinical Practice
Sara van Gennep, Nanne K de Boer, Geert R D'Haens, et al.
Digestive Diseases and Sciences
|
December 8, 2011
Two brothers with skewed thiopurine metabolism in ulcerative colitis treated successfully with allopurinol and mercaptopurine dose reduction
Frank Hoentjen, Stephen B Hanauer, Nanne K de Boer, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 62) with videos related to
Sort By:
Page
of 7
The Lancet. Gastroenterology & Hepatology
|
April 14, 2017
A plea for TDM-based optimisation for treatment of Crohn's disease
Margien L Seinen, Nanne K de Boer
Alimentary Pharmacology & Therapeutics
|
August 16, 2025
Editorial: Dual Advanced Therapy in Refractory Ulcerative Colitis-Hope Beyond Monotherapy
Ahmed B Bayoumy, Nanne K de Boer
Journal of Crohn'S & Colitis
|
January 13, 2022
The Thiopurine Tale: An Unexpected Journey
Femke Crouwel, Hans J C Buiter, Nanne K de Boer
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 7, 2020
Discontinuation rate of azathioprine
Femke Crouwel, Hans J C Buiter, Nanne K de Boer
Journal of Crohn'S & Colitis
|
July 12, 2020
Gut microbiota-driven drug metabolism in inflammatory bowel disease
Femke Crouwel, Hans J C Buiter, Nanne K de Boer
Journal of Crohn'S & Colitis
|
January 9, 2022
The Launch of an Online National Multidisciplinary Expert Panel for Inflammatory Bowel Disease
Nanne K de Boer, Florine L van Lookeren, Greetje J Tack
Clinical Pharmacokinetics
|
August 10, 2015
Pharmacology and Optimization of Thiopurines and Methotrexate in Inflammatory Bowel Disease
Mehmet Coskun, Casper Steenholdt, Nanne K de Boer, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
March 21, 2019
Key insights from therapeutic drug monitoring in Crohn's disease patients
Margien L Seinen, Nanne K De Boer, Adriaan A van Bodegraven
Inflammatory Bowel Diseases
|
December 23, 2017
Thiopurine Treatment in Ulcerative Colitis: A Critical Review of the Evidence for Current Clinical Practice
Sara van Gennep, Nanne K de Boer, Geert R D'Haens, et al.
Digestive Diseases and Sciences
|
December 8, 2011
Two brothers with skewed thiopurine metabolism in ulcerative colitis treated successfully with allopurinol and mercaptopurine dose reduction
Frank Hoentjen, Stephen B Hanauer, Nanne K de Boer, et al.
Page
of 7